Gene–environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study

[1]  K. Czene,et al.  Birth weight, breast cancer susceptibility loci, and breast cancer risk , 2010, Cancer Causes & Control.

[2]  D. Cox,et al.  Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[3]  K. Matsuo,et al.  FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: Results of a case control study in Japan , 2009, International journal of cancer.

[4]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[5]  W. Willett,et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.

[6]  V. Beral,et al.  Moderate alcohol intake and cancer incidence in women. , 2009, Journal of the National Cancer Institute.

[7]  V. Beral,et al.  Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis , 2009, British Journal of Cancer.

[8]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[9]  T. Rebbeck,et al.  Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. , 2008, Carcinogenesis.

[10]  D. Cox,et al.  Variation in the FGFR 2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer , 2009 .

[11]  Hongbing Shen,et al.  Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. , 2008, Carcinogenesis.

[12]  R. Vaillancourt,et al.  MAP3Ks as central regulators of cell fate during development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[13]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[14]  L. Shulman,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2008 .

[15]  J. Klijn,et al.  Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases , 2007, Breast Cancer Research.

[16]  V. Beral,et al.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.

[17]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[18]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[19]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[20]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[21]  Valerie Beral,et al.  Breast cancer and hormone-replacement therapy in the Million Women Study , 2003, The Lancet.

[22]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[23]  R. Goldbohm,et al.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.

[24]  V. Beral,et al.  Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. , 2001, Journal of epidemiology and biostatistics.

[25]  The ESUB-MG Study Group.  The Million Women Study: design and characteristics of the study population , 1999, Breast Cancer Research.

[26]  K. Ebeling,et al.  [Epidemiology of breast cancer]. , 1988, Archiv fur Geschwulstforschung.